MoneyWorks4Me

Unichem Laboratories sells balance stake in Optimus Drugs

05 Dec 2023 Evaluate

Unichem Laboratories has sold balance 4918 equity shares representing 0.02% holding in Optimus Drugs to Sekhmet Pharmaventures for an aggregate consideration of Rs 67.47 crore. In May 2022, the company sold 19.97% of equity shares of Optimus to Sekhmet Pharmaventures on a fully diluted basis in the first tranche, for an aggregate consideration of Rs 270.99 crore.

Unichem Laboratories is an international, integrated, specialty pharmaceutical company.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..